Covestro Begins Local Medical-Grade TPU Production in Taiwan
26 Jun 2025
2 Min Read
CW Team
Covestro has launched localised production of medical-grade Thermoplastic Polyurethane (TPU) at its Changhua site in Taiwan, marking its first such facility in the Asia Pacific region. The site, now qualified for medical-grade TPU manufacturing, will produce Desmopan® Rx grades, enabling faster and more secure regional supply for high-performance medical applications.
This is Covestro’s second global site after New Martinsville, North America, to manufacture medical-grade TPU. The move reflects rising demand driven by improved healthcare standards and an ageing global population.
Meeting Global Standards, Serving Regional Needs
Manufactured in line with Good Manufacturing Practice (GMP) guidelines, Desmopan® Rx grades meet international medical standards including ISO 10993 and China’s YY/T 1557, ensuring biocompatibility and minimised contamination risks. Free from added plasticisers, the TPU grades offer low extractables and are compatible with multiple sterilisation methods.
Dr Frank Yang, Head of Asia-Pacific Innovation TPU at Covestro, stated: “Our Desmopan® Rx grades meet established medical industry standards. This production shift ensures product safety, compliance, and timely delivery for regulated Asian markets.�
Designed for Advanced Medical Use
Desmopan® Rx TPUs are tailored for a wide range of medical devices, including tubing, catheters, connectors, housings, endoscopes, and wearable devices. Their use spans surgical procedures, drug delivery, dialysis, wound care, and more.
The material’s benefits include:
- Biocompatibility for patient-contact use
- High clarity for medical observation
- Kink resistance for uninterrupted fluid flow
- Excellent chemical and abrasion resistance
- Superior flexibility and dimensional stability
Additionally, Desmopan® Rx is suitable for melt-blown medical nonwovens used in drapes, gowns, sterile packaging, and PPE, offering strong performance while complying with medical waste regulations.
Strengthening Regional Infrastructure
The Changhua facility complements Covestro’s Zhuhai production base and its new application development centre in Guangzhou, enhancing local innovation and delivery capabilities. Kevin Ho, Head of Sales and Market Development TPU Asia Pacific, noted, “With Changhua online, we can now shorten lead times and improve supply reliability for the region.�
Covestro is showcasing the Desmopan® Rx range at Booth N5E24 during CPHI & PMEC China, running through 26 June at the Shanghai New International Expo Center.
Covestro has launched localised production of medical-grade Thermoplastic Polyurethane (TPU) at its Changhua site in Taiwan, marking its first such facility in the Asia Pacific region. The site, now qualified for medical-grade TPU manufacturing, will produce Desmopan® Rx grades, enabling faster and more secure regional supply for high-performance medical applications.This is Covestro’s second global site after New Martinsville, North America, to manufacture medical-grade TPU. The move reflects rising demand driven by improved healthcare standards and an ageing global population.Meeting Global Standards, Serving Regional NeedsManufactured in line with Good Manufacturing Practice (GMP) guidelines, Desmopan® Rx grades meet international medical standards including ISO 10993 and China’s YY/T 1557, ensuring biocompatibility and minimised contamination risks. Free from added plasticisers, the TPU grades offer low extractables and are compatible with multiple sterilisation methods.Dr Frank Yang, Head of Asia-Pacific Innovation TPU at Covestro, stated: “Our Desmopan® Rx grades meet established medical industry standards. This production shift ensures product safety, compliance, and timely delivery for regulated Asian markets.”Designed for Advanced Medical UseDesmopan® Rx TPUs are tailored for a wide range of medical devices, including tubing, catheters, connectors, housings, endoscopes, and wearable devices. Their use spans surgical procedures, drug delivery, dialysis, wound care, and more.The material’s benefits include:Biocompatibility for patient-contact useHigh clarity for medical observationKink resistance for uninterrupted fluid flowExcellent chemical and abrasion resistanceSuperior flexibility and dimensional stabilityAdditionally, Desmopan® Rx is suitable for melt-blown medical nonwovens used in drapes, gowns, sterile packaging, and PPE, offering strong performance while complying with medical waste regulations.Strengthening Regional InfrastructureThe Changhua facility complements Covestro’s Zhuhai production base and its new application development centre in Guangzhou, enhancing local innovation and delivery capabilities. Kevin Ho, Head of Sales and Market Development TPU Asia Pacific, noted, “With Changhua online, we can now shorten lead times and improve supply reliability for the region.”Covestro is showcasing the Desmopan® Rx range at Booth N5E24 during CPHI & PMEC China, running through 26 June at the Shanghai New International Expo Center.
Next Story
Singh Gives CDS Power To Issue Unified Orders For Three Services
In a stride towards modernising defence governance, Raksha Mantri Shri Rajnath Singh has empowered the Chief of Defence Staff and Secretary, Department of Military Affairs, to release Joint Instructions and Joint Orders binding on the Army, Navy and Air Force. This replaces the long-standing practice of each Service issuing separate directives whenever a matter concerned more than one branch.The first such Joint Order, published on 24 June 2025 and titled Approval, Promulgation and Numbering of Joint Instructions and Joint Orders, sets out a common framework for drafting, numbering and dissemi..
Next Story
Army Signs Rs 19.8 Billion Deals For Counter-Terror Kit
The Ministry of Defence has sealed thirteen emergency-procurement contracts worth about Rs 19.82 billion (against an overall allocation of Rs 20 billion) to sharpen the Indian Army’s counter-terrorism edge. Concluded on an accelerated fast-track basis, the packages will raise situational awareness, mobility, protection and fire-power for troops in high-risk zones.What’s on orderIntegrated Drone Detection & Interdiction SystemsLow-Level Lightweight RadarsVSHORADS launchers and missilesRemotely-piloted aerial vehicles and other tactical dronesLoitering munitions with vertical take-off an..
Next Story
Exim Bank Conclave Pushes Export-Led Growth Vision
Union Finance Minister Nirmala Sitharaman told the Exim Bank Trade Conclave 2025 that the bank’s pioneering Trade Assistance Programme (TAP) is opening high-risk markets to Indian exporters, with partnerships in more than 100 overseas banks enabling some 1,100 export deals across 51 countries since 2022.She listed Government measures fuelling export-led growth: record investment in transport and logistics, fresh credit channels for MSMEs via ITFS and Exim Finserve, revamped guarantees and the Ubharte Sitaare scheme. Cluster-based trade is advancing under the Districts as Export Hubs initiati..